UNSPSC 41202065: Treponema pallidumnontreponemal test reagents

In this classification, Treponema pallidum nontreponemal test reagents are devices used in test to identify specific Treponema pallidum nontreponemal test reagents antibodies in serum. US FDA regulates Treponema pallidum nontreponemal test reagents under 21 CFR 866.3820 and under FDA product code GMQ.

UNSPSC 41202065 Treponema pallidumnontreponemal test reagents is a Commodity code that state and local governments use to procure diagnostic test kits and reagents for syphilis and concurrent disease screening. Recent solicitations show that the work encompasses rapid immunoassay test kits (such as Abbott Determine HIV/Syphilis products), reagent supplies for automated laboratory analyzers, control kits, calibrators, and related consumables required to maintain continuous diagnostic testing operations. The issuing bodies include state departments of public health, county criminal-justice and community-supervision agencies, city health departments, and universities operating clinical laboratories. The Illinois Department of Public Health and Collin County (Texas) Community Supervision and Corrections Department appear as repeat buyers with recent activity spanning 2026. Scope varies from high-volume automated screening (thousands of tests annually on systems like the Abbott ARCHITECT i1000SR) to clinical point-of-care rapid testing (hundreds of units annually) to forensic and offender-monitoring applications with immunoassay and confirmatory methodologies.

Recent activity concentrates in Texas and Illinois. The Illinois Department of Public Health posted an Invitation for Bid on February 13, 2026 (due March 16, 2026) for a five-year contract with renewal options to supply Hepatitis, HIV, and Syphilis fourth-generation screening assays and instrumentation in Jackson County, with estimated annual volumes of approximately 13,200 HIV tests and 11,000 Syphilis tests on a fully automated platform. Collin County posted an RFP on July 9, 2026 (due July 23, 2026) for offender specimen collection and drug testing services, with approximately 25,031 annual tests including five-panel and six-panel screens, and a two-year contract value of $600,000. The City of Austin issued an IFB on June 15, 2026 (due July 17, 2026) for rapid HIV test kits (Abbott Determine HIV 1/2) to support the public health program, requiring all-inclusive pricing with no separate shipping or administrative charges. The Illinois Department of Public Health also conducted emergency sole-source procurements with Abbott Laboratories in February and May 2026 for HIV and Syphilis reagent kits and related supplies.